Evidence map›Paper›PMID 39833814›Full record

ArticleBMC public health2025

Assessing the development of health technology assessment in Iran: a policy analysis using Kingdon's Multiple streams framework: a qualitative study.

Meysam Behzadifar, Saeed Shahabi, Ahad Bakhtiari, Samad Azari, Seyed Jafar Ehsanzadeh, Mohammad Yarahmadi, Masoud Behzadifar

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meysam BehzadifarSocial Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Saeed ShahabiHealth Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ahad BakhtiariHealth Equity Research Center (HERC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Samad AzariHospital Management Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Seyed Jafar EhsanzadehEnglish Language Department, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Mohammad YarahmadiDepartment of Medical Parasitology and Mycology, Lorestan University of Medical Sciences, Khorramabad, Iran.
Masoud BehzadifarSocial Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. masoudbehzadifar@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealth Technology Assessment (HTA) is crucial for optimizing healthcare investments and improving system efficiency. In Iran, the rising costs of healthcare technologies and systemic inefficiencies have highlighted the need for a structured HTA framework. However, despite academic discussions, HTA has not yet been fully integrated into formal health policy. This study explores the development of HTA in Iran using Kingdon's Multiple Streams Framework to identify challenges and opportunities for its advancement.

methodsThe study employed qualitative methods, including 16 semi-structured interviews with key stakeholders in Iran's healthcare system. Participants, consisting of 12 males and 4 females with an average age of 41.56 years and an average work experience of 14.37 years, provided insights into the current state of HTA. The participants included individuals in key leadership roles within public and private institutions, such as the Ministry of Health and Medical Education, hospital managers, policymakers, and senior academics. Data were analyzed using Kingdon's framework to examine the problem, policy, and politics streams, as well as the role of policy entrepreneurs and potential policy windows.

resultsFindings revealed that the rising costs of healthcare technologies, particularly imported ones, and inefficiencies in technology use were major concerns. Participants indicated that HTA could address these issues by ensuring cost-effectiveness and better health outcomes. Despite the technical feasibility of implementing HTA in Iran, there is a significant gap between theoretical discussions and policy action. Resistance from the private sector and the need for political backing were identified as major barriers. However, the political climate in Iran is becoming increasingly favorable, with growing interest in healthcare efficiency and transparency. The Covid-19 pandemic and healthcare shortages have exposed vulnerabilities, presenting potential opportunities for HTA's adoption. Leadership roles in key institutions, including the Ministry of Health and Medical Education, were identified as vital to advancing HTA initiatives. Policy entrepreneurs play a crucial role in advocating for HTA and capitalizing on these opportunities.

conclusionHTA is recognized as a valuable tool for improving healthcare efficiency and equity in Iran. However, significant challenges remain in transitioning from academic discussions to formal policy. The political environment and recent healthcare crises offer opportunities to advance HTA. To successfully integrate HTA into Iran's healthcare system, it is essential to address existing barriers, leverage political interest, and support policy entrepreneurs. The experiences of other countries, especially those with strong institutional leadership in HTA, provide useful models for Iran to follow in its HTA development journey.

Indexed as

Health PolicyPolicy MakingTechnology Assessment, BiomedicalAdultFemaleHumansInterviews as TopicIranMaleMiddle AgedQualitative ResearchHealth policyHealth technology assessmentIranKingdon’s Multiple streams frameworkPolicy entrepreneurs

Identifiers

PMID39833814
PMCPMC11745027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.